Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation

Journal of Neuroimmunology

Volumn 214, Issue 1-2, 2009, Pages 25-32

  Pocivavsek, Ana ^a   Mikhailenko, Irina ^b   Strickland, Dudley K ^b   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; JNK; LPS; Nitric oxide; Signal transduction

Indexed keywords

APOLIPOPROTEIN E; CRE RECOMBINASE; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PEPTIDE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENCEPHALITIS; MICROGLIA; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TISSUE SPECIFICITY;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LDL-RECEPTOR RELATED PROTEIN 1; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE;

EID: 69949112770     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.06.010     Document Type: Article

References (71)

1. Ard M.D., Cole G.M., Wei J., Mehrle A.P., and Fratkin J.D. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43 (1996) 190-202
2. Arelin K., Kinoshita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland D.K., and Hyman B.T. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res. Mol. Brain Res. 104 (2002) 38-46
3. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., and Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11551-11556
4. Bales K.R., Du Y., Holtzman D., Cordell B., and Paul S.M. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol. Aging 21 (2000) 427-432 discussion 451-423
5. Bales K.R., Liu F., Wu S., Lin S., Koger D., DeLong C., Hansen J.C., Sullivan P.M., and Paul S.M. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29 (2009) 6771-6779
6. Beffert U., Stolt P.C., and Herz J. Functions of lipoprotein receptors in neurons. J. Lipid Res. 45 (2004) 403-409
7. Bhat N.R., Zhang P., Lee J.C., and Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18 (1998) 1633-1641
8. Boje K.M., and Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587 (1992) 250-256
9. Bu G., Cam J., and Zerbinatti C. LRP in amyloid-beta production and metabolism. Ann. N.Y. Acad. Sci. 1086 (2006) 35-53
10. Bugge T.H., Xiao Q., Kombrinck K.W., Flick M.J., Holmback K., Danton M.J., Colbert M.C., Witte D.P., Fujikawa K., Davie E.W., and Degen J.L. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6258-6263
11. Christie R.H., Chung H., Rebeck G.W., Strickland D., and Hyman B.T. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 491-498
12. Combs C.K., Karlo J.C., Kao S.C., and Landreth G.E. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21 (2001) 1179-1188
13. Corradin S.B., Mauel J., Donini S.D., Quattrocchi E., and Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7 (1993) 255-262
14. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Lenting P.J., Van Nostrand W.E., and Zlokovic B.V. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 (2004) 333-344
15. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., and Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277 (1997) 693-696
16. Dong L.M., and Weisgraber K.H. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271 (1996) 19053-19057
17. Gotthardt M., Trommsdorff M., Nevitt M.F., Shelton J., Richardson J.A., Stockinger W., Nimpf J., and Herz J. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275 (2000) 25616-25624
18. Han I.O., Kim K.W., Ryu J.H., and Kim W.K. p38 mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Neurosci. Lett. 325 (2002) 9-12
19. Hatters D.M., Peters-Libeu C.A., and Weisgraber K.H. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 31 (2006) 445-454
20. Herz J. The LDL receptor gene family: (un)expected signal transducers in the brain. Neuron 29 (2001) 571-581
21. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., and Wellington C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279 (2004) 41197-41207
22. Hoe H.S., and Rebeck G.W. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res. Mol. Brain Res. 137 (2005) 31-39
23. Hoe H.S., Harris D.C., and Rebeck G.W. Multiple pathways of apolipoprotein E signaling in primary neurons. J. Neurochem. 93 (2005) 145-155
24. Hoe H.S., Pocivavsek A., Dai H., Chakraborty G., Harris D.C., and Rebeck G.W. Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Res. 1112 (2006) 70-79
25. Hu K., Yang J., Tanaka S., Gonias S.L., Mars W.M., and Liu Y. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281 (2006) 2120-2127
26. Hu L., Boesten L.S., May P., Herz J., Bovenschen N., Huisman M.V., Berbee J.F., Havekes L.M., van Vlijmen B.J., and Tamsma J.T. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2710-2715
27. Kim D.H., Iijima H., Goto K., Sakai J., Ishii H., Kim H.J., Suzuki H., Kondo H., Saeki S., and Yamamoto T. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271 (1996) 8373-8380
28. Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., and Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 48 (2005) 196-206
29. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and van Eldik L.J. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J. Biol. Chem. 275 (2000) 33974-33980
30. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and Van Eldik L.J. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem. Int. 39 (2001) 427-434
31. Laskowitz D.T., Goel S., Bennett E.R., and Matthew W.D. Apolipoprotein E suppresses glial cell secretion of TNF alpha. J. Neuroimmunol. 76 (1997) 70-74
32. Laskowitz D.T., Matthew W.D., Bennett E.R., Schmechel D., Herbstreith M.H., Goel S., and McMillian M.K. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport 9 (1998) 615-618
33. Laskowitz D.T., Lee D.M., Schmechel D., and Staats H.F. Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res. 41 (2000) 613-620
34. Laskowitz D.T., Thekdi A.D., Thekdi S.D., Han S.K., Myers J.K., Pizzo S.V., and Bennett E.R. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp. Neurol. 167 (2001) 74-85
35. Lillis A.P., Greenlee M.C., Mikhailenko I., Pizzo S.V., Tenner A.J., Strickland D.K., and Bohlson S.S. Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. J. Immunol. 181 (2008) 364-373
36. Lillis A.P., Van Duyn L.B., Murphy-Ullrich J.E., and Strickland D.K. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88 (2008) 887-918
37. Lynch J.R., Morgan D., Mance J., Matthew W.D., and Laskowitz D.T. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J. Neuroimmunol. 114 (2001) 107-113
38. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., and Laskowitz D.T. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278 (2003) 48529-48533
39. Mace B.E., Wang H., Lynch J.R., Moss J., Sullivan P., Colton H., Morgan K., Renauld J.C., and Laskowitz D.T. Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol. Res. 29 (2007) 243-250
40. Marzolo M.P., von Bernhardi R., Bu G., and Inestrosa N.C. Expression of alpha(2)-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J. Neurosci. Res. 60 (2000) 401-411
41. May P., Reddy Y.K., and Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277 (2002) 18736-18743
42. McGeer P.L., and McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22 (2001) 799-809
43. McGeer P.L., and McGeer E.G. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch. Neurol. 58 (2001) 1790-1792
44. Meda L., Cassatella M.A., Szendrei G.I., Otvos Jr. L., Baron P., Villalba M., Ferrari D., and Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374 (1995) 647-650
45. Misra U.K., Gawdi G., and Pizzo S.V. Ligation of low-density lipoprotein receptor-related protein with antibodies elevates intracellular calcium and inositol 1,4, 5-trisphosphate in macrophages. Arch. Biochem. Biophys. 372 (1999) 238-247
46. Moon D.O., Park S.Y., Lee K.J., Heo M.S., Kim K.C., Kim M.O., Lee J.D., Choi Y.H., and Kim G.Y. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharmacol. 7 (2007) 1092-1101
47. Mooney L.M., and Whitmarsh A.J. Docking interactions in the c-Jun N-terminal kinase pathway. J. Biol. Chem. 279 (2004) 11843-11852
48. Newton C.S., Loukinova E., Mikhailenko I., Ranganathan S., Gao Y., Haudenschild C., and Strickland D.K. Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J. Biol. Chem. 280 (2005) 27872-27878
49. Paresce D.M., Ghosh R.N., and Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17 (1996) 553-565
50. Parks A.L., and Curtis D. Presenilin diversifies its portfolio. Trends Genet. 23 (2007) 140-150
51. Pietrzik C.U., Busse T., Merriam D.E., Weggen S., and Koo E.H. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J. 21 (2002) 5691-5700
52. Pocivavsek A., Burns M.P., and Rebeck G.W. Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia 57 (2009) 444-453
53. Polavarapu R., Gongora M.C., Yi H., Ranganthan S., Lawrence D.A., Strickland D., and Yepes M. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109 (2007) 3270-3278
54. Pyo H., Jou I., Jung S., Hong S., and Joe E.H. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 9 (1998) 871-874
55. Rebeck G.W., Reiter J.S., Strickland D.K., and Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11 (1993) 575-580
56. Riddell D.R., Zhou H., Atchison K., Warwick H.K., Atkinson P.J., Jefferson J., Xu L., Aschmies S., Kirksey Y., Hu Y., Wagner E., Parratt A., Xu J., Li Z., Zaleska M.M., Jacobsen J.S., Pangalos M.N., and Reinhart P.H. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 28 (2008) 11445-11453
57. Ruiz J., Kouiavskaia D., Migliorini M., Robinson S., Saenko E.L., Gorlatova N., Li D., Lawrence D., Hyman B.T., Weisgraber K.H., and Strickland D.K. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J. Lipid Res. 46 (2005) 1721-1731
58. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
59. Ulery P.G., and Strickland D.K. LRP in Alzheimer's disease: friend or foe?. J. Clin. Invest. 106 (2000) 1077-1079
60. Ulery P.G., Beers J., Mikhailenko I., Tanzi R.E., Rebeck G.W., Hyman B.T., and Strickland D.K. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275 (2000) 7410-7415
61. Vitek M.P., Brown C.M., and Colton C.A. APOE genotype-specific differences in the innate immune response. Neurobiol. Aging (2007)
62. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., Kowalewski T., and Holtzman D.M. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279 (2004) 40987-40993
63. Wang X., Lee S.R., Arai K., Tsuji K., Rebeck G.W., and Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9 (2003) 1313-1317
64. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45 (1994) 249-302
65. Whitmarsh A.J., Kuan C.Y., Kennedy N.J., Kelkar N., Haydar T.F., Mordes J.P., Appel M., Rossini A.A., Jones S.N., Flavell R.A., Rakic P., and Davis R.J. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15 (2001) 2421-2432
66. Willoughby E.A., Perkins G.R., Collins M.K., and Whitmarsh A.J. The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK. J. Biol. Chem. 278 (2003) 10731-10736
67. Xie Z., Smith C.J., and Van Eldik L.J. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45 (2004) 170-179
68. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., and Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112 (2003) 1533-1540
69. Zhang X., Polavarapu R., She H., Mao Z., and Yepes M. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation. Am. J. Pathol. 171 (2007) 1281-1290
70. Zhang C., An J., Strickland D.K., and Yepes M. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am. J. Pathol. 174 (2009) 586-594
71. Zurhove, K., Nakajima, C., Herz, J., Bock, H.H., May, P., 2008. Gamma-secretase limits the inflammatory response through the processing of LRP1. Sci Signal 1, ra15.